MENU
CGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cognition Therapeutics (CGTX) Earnings Date & Reports

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina... Show more

A.I. Advisor
published Earnings

CGTX is expected to report earnings to fall 40.38% to -11 cents per share on May 07

Cognition Therapeutics CGTX Stock Earnings Reports
Q1'25
Est.
$-0.11
Q4'24
Missed
by $0.02
Q3'24
Missed
by $0.05
Q2'24
Beat
by $0.06
Q1'24
Missed
by $0.02
The last earnings report on March 20 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 312.00K shares outstanding, the current market capitalization sits at 25.59M.
View a ticker or compare two or three
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
28
Web
https://www.cogrx.com